Www.dpiresearch.com
This presentation is the property of its rightful owner.
Sponsored Links
1 / 6

United States Influenza Vaccine Market,Production, Distribution and Forecas... PowerPoint PPT Presentation


United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details. The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market. Major and Promising Vaccine covered in the report are as follows:1. Fluzone High–Dose2. Fluzone Quadrivalent3. Intradermal (ID) Trivalent 4. Vaxigrip 5. Fluarix Quadrivalent 6. Flulaval Quadrivalent7. Fluenz Tetra 8. FluMist Quadrivalent 9. Flublok10. VN–10011. M–001 12. VAX–2012Q 13. TAK – 850 14. Flucelvax Quadrivalent 15. Afluria Quadrivalent16. Agrippal17. Fluad 18. Fluvirin19. Fluvax Key Companies Covered in the Report are as follows1. Sanofi Pasteur 2. GlaxoSmithKline(GSK) 3. Seqirus4. AstraZenecca 5. Protein Sciences Corporation6. Novavax 7. Daiichi–Sankyo 8. Mitsubishi Tanabe Pharma 9. BiondVax Pharmaceuticals Ltd10. VaxInnateContact Info:Name: Maria Rai,Sales ManagerEmail: [email protected]: DPI ResearchPhone: 91 728-994-9987

Download Presentation

United States Influenza Vaccine Market,Production, Distribut...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


United states influenza vaccine market production distribution and forecast to 2022

www.dpiresearch.com


United states influenza vaccine market production distribution and forecast to 2022

United States Influenza Vaccine Market

Publish Date : 1

Publish Date : 1st

stDecember 2016

December 2016

No. of Pages : 122

No. of Pages : 122

Geography Coverage : United States

Geography Coverage : United States

Price for Single User Licence : USD 1000

Price for Single User Licence : USD 1000

Price for Global User Licence : USD 1400

Price for Global User Licence : USD 1400

Delivery Time : Within 24 hours

Delivery Time : Within 24 hours

www.dpiresearch.com


United states influenza vaccine market production distribution and forecast to 2022

United States Influenza Vaccine Market

United

States

Influenza

Vaccine

Market

is

expected to reach more than US$ 2.5 Billion by

the year end of 2022.

Market growth can be attributed to factors such

as

increased

disease

awareness,

expanded

recommendations by governmental and advisory

bodies to be vaccinated against influenza vaccine

and

introduction

of

quadrivalent

influenza

vaccine.

www.dpiresearch.com


United states influenza vaccine market production distribution and forecast to 2022

United States Influenza Vaccine Market

Report Coverage:

1. Executive Summary

2. United States Influenza Vaccine Market & Forecast

3. United States Number of Persons Vaccinated with

Influenza Vaccine

4. United States Influenza Vaccine Market Drivers and

Barriers

5. United

Distribution

States

Influenza

Vaccine

Production

&

www.dpiresearch.com


United states influenza vaccine market production distribution and forecast to 2022

United States Influenza Vaccine Market

Report Coverage Continues:

6.

Regulatory Landscape

United

States

Influenza

Vaccine

Market

7. Market Dynamics – Mergers, Acquisitions, Key

Agreements & Collaborations

8. Influenza Vaccine – Pipeline Assessment

9. Influenza Vaccine – Clinical Trials Assessment by

Phase and Trial Status

10. Key Companies Analysis

www.dpiresearch.com


United states influenza vaccine market production distribution and forecast to 2022

United States Influenza Vaccine Market

How to Buy this Report?

Visit following URL to see Table of Content and purchase

this publication:

http://www.dpiresearch.com/report-details.php?P_ID=88

Contact us: [email protected]

For More Details visit: www.dpiresearch.com

www.dpiresearch.com


  • Login